How do I tell if GPCR is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Structure Therapeutics Inc. American Depositary Shares (GPCR) Stock

Q: What is the minimum investment for GPCR on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Structure Therapeutics Inc. American Depositary Shares from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · GPCR

Trade GPCR

Key stats

Market cap: $1.49B
Price / Earnings ratio: -5.3x
EPS (TTM): -$3.90
Volume: Loading
52-week high: $94.90
52-week low: $18.70

Source: third-party data provider, as of November 13, 2026

Compare with GPCR

Technical indicators

RSI 14: 35.80
MACD 12/26/9: -2.23
EMA 9 of MACD: -2.88
MACD histogram: 0.65
SMA 50: $28.99; Price below SMA 50
EMA 50: $28.36; Price below EMA 50
SMA 200: $46.28; Price below SMA 200
EMA 200: $43.77; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 1 analyst rating

Strong Sell0

Sell0

Hold0

Buy1

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

0000

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

2B1B627M0

Revenue to Profit

2025

$0.0

Revenue

$0.0

Cost of revenue

$0.0

Gross profit

$0.0

Operating expenses

$-141.2M

Net income

Earnings

EPS forecast

Actual EPS

$-0.37

Q1FY26

$-0.37

Q2FY26

$-0.38

Q3FY26

The market is expecting earnings per share of -$0.38 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Structure Therapeutics Inc. American Depositary Shares

No description available.

SectorHealthcare

IndustryBiotechnology

Employees281

CEODr. Raymond C. Stevens Ph.D.

IPO DateFeb 3, 2023

HeadquartersSouth San Francisco, CA

Key Executives

Name	Title	Year Born
Dr. Raymond C. Stevens Ph.D.	CEO & Director	1964
Mr. Jun S. Yoon	Co- Founder, CFO & Secretary	1978
Mr. Matthew Lang J.D.	COO & General Counsel	1976
Dr. Yingli Ma Ph.D.	Chief Technology Officer	1974
Dr. Xichen Lin Ph.D.	Chief Scientific Officer & GM of Structure Shanghai	1974
Dr. Blai Coll M.D., Ph.D.	Chief Medical Officer	1974
Mr. Bob Gatmaitan	Senior Vice President of People	—
Dr. Hui Lei Ph.D.	Senior Vice President of Chemistry	—
Dr. Fang Zhang Ph.D.	Executive VP & Head of Biology	—
Ms. Lani Ibarra	Senior Vice President of Clinical Development Operations	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2023		-1.7	+3.8	-2.8	+30.6	+29.6	-11.5	-22.6	+71.7	+31.3	-24.6	-31.6
2024	+8.0	-10.0	+3.9	-3.6	-13.0	-25.5	-6.5	+4.7	+15.0	-2.5	-19.4	-20.1
2025	+6.3	-16.2	-22.5	+71.0	-20.4	-4.8	-13.2	+9.7	+39.4	+28.0	+9.3	+101.2
2026	+29.8	-29.9	-23.4	-17.4	-6.8	+39.2	-7.8	-5.1	-33.7	-24.5	+2.3

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Structure Therapeutics Inc. American Depositary Shares (GPCR) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "GPCR", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy GPCR by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Structure Therapeutics Inc. American Depositary Shares from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Structure Therapeutics Inc. American Depositary Shares (GPCR) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track GPCR's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Structure Therapeutics Inc. American Depositary Shares (GPCR) Stock

Key stats

Compare with GPCR

Recent news

Novo Down 11% in a Month: How Should Investors Approach the Stock Now?

Novo Down 11% in a Month: How Should Investors Approach the Stock Now?

VKTX Stock On Track To Beat LLY, NVO This Month After Obesity Drug Data — Can Viking Win Over Wegovy And Zepbound Users?

VKTX Stock On Track To Beat LLY, NVO This Month After Obesity Drug Data — Can Viking Win Over Wegovy And Zepbound Users?

VKTX, GPCR, ALT Stocks Rise: Novo Nordisk Signals Bigger M&A As It Chases Over 5 ‘Multi-Blockbusters’

VKTX, GPCR, ALT Stocks Rise: Novo Nordisk Signals Bigger M&A As It Chases Over 5 ‘Multi-Blockbusters’

LLY Stock Down Around 7% in a Month: Buy the Dip or Stay Cautious?

LLY Stock Down Around 7% in a Month: Buy the Dip or Stay Cautious?

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Novo Down 11% in a Month: How Should Investors Approach the Stock Now?

Novo Down 11% in a Month: How Should Investors Approach the Stock Now?

VKTX Stock On Track To Beat LLY, NVO This Month After Obesity Drug Data — Can Viking Win Over Wegovy And Zepbound Users?

VKTX Stock On Track To Beat LLY, NVO This Month After Obesity Drug Data — Can Viking Win Over Wegovy And Zepbound Users?

VKTX, GPCR, ALT Stocks Rise: Novo Nordisk Signals Bigger M&A As It Chases Over 5 ‘Multi-Blockbusters’

VKTX, GPCR, ALT Stocks Rise: Novo Nordisk Signals Bigger M&A As It Chases Over 5 ‘Multi-Blockbusters’

LLY Stock Down Around 7% in a Month: Buy the Dip or Stay Cautious?

LLY Stock Down Around 7% in a Month: Buy the Dip or Stay Cautious?

Novo Nordisk's Semaglutide Meets Goal in Pediatric Obesity Study

Novo Nordisk's Semaglutide Meets Goal in Pediatric Obesity Study

NVO vs. GPCR: Which Obesity Stock Is the Better Buy Right Now?

NVO vs. GPCR: Which Obesity Stock Is the Better Buy Right Now?

LLY Up Around 6% Post Robust Q2 Results: Buy, Sell or Hold the Stock?

LLY Up Around 6% Post Robust Q2 Results: Buy, Sell or Hold the Stock?

VKTX Stock Lags GLP-1 Peers In July — But Viking CEO Says Its Obesity Drug Could Offer What Rivals Can’t

VKTX Stock Lags GLP-1 Peers In July — But Viking CEO Says Its Obesity Drug Could Offer What Rivals Can’t

The Next Phase Of The Obesity Drug Race

The Next Phase Of The Obesity Drug Race

Structure's experimental obesity pill shows no signs of liver injury

Structure's experimental obesity pill shows no signs of liver injury

About Structure Therapeutics Inc. American Depositary Shares

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade